Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosol vs Intradermal BCG Challenge in Healthy Adults
NCT02709278Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Mar 2016
- Primary completion
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bcg vaccine in Tuberculosis (TB) (10 arms), sponsored by University of Oxford. Primary endpoint: Adverse Events. Started Mar 2016; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02709278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709278.